Safety and efficacy of eltrombopag (epag) versus placebo (pbo) for the treatment (tx) of chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors receiving gemcitabine (gem)-based chemotherapy (ctx): A phase I study.
Eric S. Winer
No relevant relationships to disclose
Howard Safran
No relevant relationships to disclose
Boguslawa Karaszewska
No relevant relationships to disclose
Donald A. Richards
No relevant relationships to disclose
Lee Hartner
No relevant relationships to disclose
Frederic Forget
No relevant relationships to disclose
Rodryg Ramlau
No relevant relationships to disclose
Kirushna Kumar
Research Funding - Investigator Fees
Bhabita Mayer
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Brendan Mark Johnson
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Conrad A. Messam
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Yasser Mostafa Mostafa Kamel
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Other Remuneration - GlaxoSmithKline